Neuroblastoma Daily News
Maria Lindqvist,PhD
Neuroblastom(NBL) är en hjärn tumör sjukdom hos små barn, medelåldern för de drabbade är under 2 år, och sjukdomen är extremt sällsynt hos personer över 10 år eller unga vuxna.
Neuroblastoma (NB) is a pediatric tumor that originates from neural crest-derived cells undergoing a defective differentiation due to genomic and epigenetic impairments.
Cellular differentiation, by definition, is epigenetic https://www.youtube.com/watch?v=S1QEvMY6GOw
Natural "brake" against malignant neuroblastoma
A Lack of Neuroblastoma in Down Syndrome: A Study from 11 European Countries
Global, regional, and national epidemiology of childhood neuroblastoma (1990–2021): a statistical analysis of incidence, mortality, and DALYs
International variations in neuroblastoma incidence in children and adolescents
Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma
The present study demonstrated, for the first time, a potential association between maternal occupational exposure and the occurrence of neuroblastoma in offspring.
Parental Alcohol Use Linked To Increased Cancer Risk In Children, Texas A&M Researchers Find
Per- and polyfluoroalkyl substances (PFAS) may cause various deleterious health effects. Epidemiological studies have demonstrated associations between PFAS exposure and adverse neurodevelopmental outcomes.
Chocken i Uppsala – här har barn högre halter av PFAS
Mer kemikalier i blodet hos spädbarn i Åbo än på andra orter – dricksvattnet eller stor fiskkonsumtion kan vara orsak
Ten Years of Scientific Studies Find Association Between Childhood Cancer and Pesticide Exposure
Neuroblastoma Predisposition and Surveillance—An Update from the 2023 AACR Childhood Cancer Predisposition Workshop
A mitochondria-related genes associated neuroblastoma signature - based on bulk and single-cell transcriptome sequencing data analysis, and experimental validation
Intercellular extrachromosomal DNA copy-number heterogeneity drives neuroblastoma cell state diversity
Identification and verification of international neuroblastoma staging system (INSS) stage-related genes as potential biomarkers for neuroblastoma prognostic models
Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
Vanillylmandelic acid (VMA) and homovanillic acid (HVA) are biomarkers for the diagnosis and course-of-disease monitoring of malignant tumor neuroblastomas, which endanger infants and children
A review of the biomarkers with the potential to predict poor prognosis of neuroblastoma
Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets
Potential Biomarker Found for Neuroendocrine Tumors, Neuroblastoma
Low Expression of CASP8 Could be a Prognostic Biomarker in Neuroblastoma Patients
Bioinformatics reveals the potential mechanisms and biomarkers of necroptosis in neuroblastoma
NEUROBLASTOMA TREATMENT
The American Association for Cancer Research
Umeå först ut med beslut om genetisk diagnostik av barncancer i egen regi
Genen som styr prognosen vid neuroblastom
Treatments for neuroblastoma
European Commission approves first immunotherapy for high-risk neuroblastoma patients
10 MAY 2017
Neuroblastoma Treatment in Europe
Hospitals and medical centers in Europe which treat Neuroblastoma patients.
The MONALISA project is a groundbreaking initiative aiming to improve the monitoring of children with relapsed neuroblastoma using liquid biopsies.
CCI Europe is the European branch of Childhood Cancer International (CCI). The Board of CCI is interlinked with the CCI Europe Regional Committee fostering a strong partnership and exchange of knowledge across the different geographical scopes.
The SIOPEN Association brings together clinicians and healthcare professionals from across Europe and beyond to improve the outcomes for patients with neuroblastoma.
A new era for treating high-risk neuroblastoma – research advances to look out for in 2024
Survival Rates by Risk Group for Neuroblastoma
Swissmedic approves IFINWIL for children with high-risk neuroblastoma
This approval follows previous authorisations in the US, Israel and Australia.July 9, 2025
Using 3D-bioprinted models to study pediatric neural crest-derived tumors.
Scientists solve mystery of how the drug retinoic acid works to treat neuroblastoma
nature
This is where your text starts. You can click here and start typing. Iste natus error sit voluptatem accusantium doloremque laudantium totam rem aperiam eaque ipsa quae ab.
Rem aperiam eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta.
urban landscape
This is where your text starts. You can click here and start typing. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium totam rem aperiam eaque ipsa quae ab illo inventore veritatis.
Sit voluptatem accusantium doloremque laudantium totam rem aperiam eaque ipsa.
- Berlin
- Barcelona
- Prague
book an appointment
This is where your text starts. You can click here and start typing. Accusantium doloremque laudantium totam rem aperiam eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt neque.